Immuron Files F-1 with the SEC MELBOURNE, Australia, Dec.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Immuron Files F-1 with the SEC

MELBOURNE, Australia, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Australian biopharmaceutical Company, Immuron Limited (ASX:IMC), is pleased to announce today that it filed its Registration Statement on Form F-1 with the United States Securities and Exchange Commission (SEC) relating to the initial public offering of its American Depository Shares (ADS).  The Registration Statement is preliminary and has not yet become effective. The Company also intends to seek the listing of its ADS on a US national stock exchange.

The number of shares proposed to be offered and sold, and the dollar amount proposed to be raised under this US Public Offering have not yet been determined and there cannot be any assurance that the Company’s IPO will be completed.    Joseph Gunnar & Co., LLC is acting as book-running manager for the offering.

The Immuron filing can be found under the Edgar database housed in the SEC website.  The registration statement, including a prospectus, which is preliminary and subject to completion, relating to these securities has been filed with the U.S. Securities and Exchange Commission, but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time that the registration statement becomes effective, and, even then, the securities may only be sold pursuant to the registration statement and final prospectus. This announcement shall not constitute an offer to sell or a solicitation of an offer to buy these securities in the United States or in any other jurisdiction, including without limitation Australia, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. A copy of the prospectus relating to this offering, when available, will be filed with the SEC and may also be obtained from Joseph Gunnar & Co., LLC, Prospectus Department, 30 Broad Street, 11th Floor, New York, NY 10004, telephone 212-440-9600, email: prospectus@jgunnar.com .

About Immuron:

Immuron Ltd (ASX:IMC) is a biopharmaceutical company focused on developing and commercialising oral immunotherapeutics for the treatment of immune mediated diseases.  Immuron has a unique and safe technology platform that enables a shorter development therapeutic cycle. The Company currently markets and sells Travelan® for the prevention of travellers’ diarrhoea, whilst its lead product candidate IMM-124E is in Phase II clinical trials for NASH, ASH and Pediatric NASH. These products together with the Company’s other preclinical immunotherapy pipeline products targeting immune-related diseases currently under development, will meet a large unmet need in the market.

For more information, visit: http://www.immuron.com/

Forward-Looking Statements:

Certain statements made in this release are forward-looking statements and are based on Immuron’s current expectations, estimates and projections. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “guidance” and similar expressions are intended to identify forward-looking statements. Although Immuron believes the forward-looking statements are based on reasonable assumptions, they are subject to certain risks and uncertainties, some of which are beyond Immuron’s control, including those risks or uncertainties inherent in the process of both developing and commercialising technology. As a result, actual results could materially differ from those expressed or forecasted in the forward-looking statements. The forward-looking statements made in this release relate only to events as of the date on which the statements are made. Immuron will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date of this release except as required by law or by any appropriate regulatory authority.

Company Contact: Thomas Liquard Chief Executive Officer Ph: +61 (0)3 9824 5254 thomasliquard@immuron.com Immuron Media Relations: John Beveridge Monsoon Communications Ph: +61 (0)3 9620 3333 johnb@monsoon.com.au

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ActivTrak's Fast 500 Rank Needs Investor Perspective

Updated Category News Views 60

Rank 488 is the sort of trophy that deserves a raised eyebrow, not confetti. ActivTrak made Deloitte's 2026 Technology Fast 500 after posting 101.1% revenue growth from 2022 through 2025, its sixth appearance on the list since 2020. That is real progress, and repeat recognition says this was not a one-quarter sugar high. Still, a Fast 500 ranking is a growth screen, not a...

Continue Reading
Ridgeline’s Dome Roof Award Signals Durable Craft Demand

Updated Category News Views 69

A faceted dome in the Alabama woods is about as far from a cookie-cutter reroof as it gets. Ridgeline Roofing & Restoration’s 2026 Excellence Award from Brava Roof Tile matters because the job in Pell City demanded the sort of painstaking field execution that separates a capable contractor from a crew merely moving shingles fast. Geometry Is Where Easy Claims Go to Die...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 85

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Valley Family Health Breach Notice Raises Hard Questions

Updated Category News Views 53

Seven months is a long time for sensitive patient data to sit inside an unresolved security story. Valley Family Health Care, Inc. says it suffered a network disruption on or about March 13, 2026, investigated with outside cybersecurity specialists, and ultimately determined that an unauthorized actor accessed and acquired certain files. The formal notification process...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 120

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 92

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Mining's Biodiversity Map Sharpens Location Risks

Updated Category News Views 106

Twelve thousand pins on a map do not settle the mining industry's nature problem, but they do make it much harder to pretend the problem is evenly spread. ICMM's new Global Mining and Metals Biodiversity Dataset overlays 12,000 large-scale formal mining, smelting, refining and processing facilities with ecosystem-condition and conservation indicators. For investors...

Continue Reading
Vector Adds Mesa Division 10 Veteran for Arizona Growth

Updated Category News Views 94

A toilet-partition deal rarely raises eyebrows, but this one has the sturdy logic investors ought to notice. Vector Building Products has acquired Mesa-based Partitions & Accessories Co., a Division 10 specialist that has served Arizona contractors since 1978. It is not glamorous work. It is, however, the sort of necessary, specification-driven business that gets embedded...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 182

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 110

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading

Top 5 Most Recently Viewed Articles

MINISH Technology's Milestone: First U.S. Veneers Certification Success

Updated Category News Views 201

MINISH Technology Concludes First U.S. Veneers Course Health-tech company MINISH Technology Inc. has recently achieved a remarkable milestone by successfully completing its first MINISH Veneers course in the United States, certifying 22 dedicated dentists. This event highlights a significant step forward in the company’s commitment to advancing dental education and...

Continue Reading
Exciting Developments for Stellar V Capital Corp.'s Trading Options

Updated Category News Views 130

Stellar V Capital Corp. Announces Upcoming Trading Changes NEW YORK — Stellar V Capital Corp., a rising star in the acquisition space, has exciting news for its investors. Beginning March 24, 2025, holders of the units sold during the Company’s initial public offering will have the option to trade the Class A ordinary shares separately from the associated warrants....

Continue Reading
DelNorte’s Groundbreaking Data Tokenization Initiative Unveiled

Updated Category News Views 1405

Revolutionizing Public Data Management with DelNorte In an exciting move aimed at improving how public data is handled, DelNorte has partnered with a significant government body to initiate a cutting-edge data tokenization project. This initiative is centered around the introduction of the DTV Token, a vital component of DelNorte's innovative Terra Vision ecosystem,...

Continue Reading
Celebrating Success at the AMPLIFY A|E|C Conference

Updated Category News Views 67

WB Engineers+Consultants at the AMPLIFY A|E|C Conference Recently, WB Engineers+Consultants was proud to represent its ethos of innovation and excellence at the AMPLIFY A|E|C 2024 conference, a key event dedicated to the architecture, engineering, and construction (A/E/C) sectors. This distinguished conference was organized by the Society for Marketing Professional...

Continue Reading
Calix Faces Legal Fire Over Alleged Securities Missteps

Updated Category News Views 51

Calix Hits a Legal Snag: What's at Stake? In the gritty world of stock trading, nothing gets folks more riled up than talk of lawsuits—and here comes Calix, Inc. (NYSE: CALX) caught in a thorny one. Straight out of Los Angeles, the DJS Law Group beams a flare into the sky, reminding investors of a class action lawsuit tagged to violations of the Securities Exchange Act...

Continue Reading